Joseph Tuscano: Clinical Trials

4 trials sponsored by Joseph Tuscano, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Unknown 1
Phase 11Completed 1

Follow Joseph Tuscano: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma
Clarithromycin, Dexamethasone, Ixazomib Citrate - Myeloma
Phase 1 / Phase 2CompletedJoseph Tuscano322015-10-222026-11-02
Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
rituximab, ibritumomab tiuxetan, anti-thymocyte globulin - Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma
Phase 2UnknownJoseph Tuscano202013-03-122022-11-30
Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma
Ofatumumab + Fresh Frozen Plasma - Chronic Lymphocytic Leukemia
Phase 2CompletedJoseph Tuscano122013-01-142021-05-11
Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
Bortezomib, Doxil - Acute Myelogenous Leukemia
Phase 2CompletedJoseph Tuscano252012-12-192021-02-24

Conditions studied

Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms, Plasma Cell (1)

Interventions

Antilymphocyte Serum (1)  ·  Bortezomib (1)  ·  Calcium Dobesilate (1)  ·  Clarithromycin (1)  ·  Cyclosporine (1)  ·  Dexamethasone (1)  ·  Mycophenolic Acid (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Rituximab (1)  ·  ibritumomab tiuxetan (1)  ·  ixazomib (1)  ·  liposomal doxorubicin (1)  ·  ofatumumab (1)  ·  pomalidomide (1)  ·  thymoglobulin (1)

Countries

United States (4)

Results publications

PMID 40948663